関連する実験動画
Updated: Sep 9, 2025

11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
8.0K
一般診療における前立腺がんの焦点療法に関するレビュー
Henry Wang1, Shravankrishna Ananthapadmanabhan2, Jake Rahkala3
1MBBS, Urology Research Fellow, Nepean Hospital, Sydney, NSW.
Australian journal of general practice
|September 5, 2025
まとめ
集中治療は局所性前立腺がんの有望な代替手段であり,従来の治療法と比較して勃起不全や incontinenceなどの副作用を軽減することを目的としています. このレビューは,これらの新興の前立腺がん治療の主要な原則,方法,結果を要約しています.
科学分野:
- 腫瘍学
- 泌尿器科
- 医療技術
背景:
- 現在進行中の前立腺がんの治療法 (手術と放射線治療) は,勃起不全や尿失禁を含む重大な副作用と関連しています.
- 焦点治療は前立腺がんの新たな治療法で 治療による副作用を最小限に抑えるように設計されています
研究 の 目的:
- 一般診療のための前立腺がんの焦点治療の要約を提供すること.
- 前立腺がんの管理における焦点療法における腫瘍学的原理,治療方法,機能的および腫瘍学的結果,およびフォローアッププロトコルを見直す.
主な方法:
- この研究は,前立腺がんの焦点療法に関する既存の文献の記述的レビューです.
- このレビューは,基礎となる腫瘍学的原理,現在の治療法,および焦点療法に関連するアウトカムに関する情報をまとめています.
主要な成果:
- 局所性前立腺がんの有効な治療法として認知されています.
- 慎重に選択された患者に従来の治療の有望な代替手段として,焦点療法を支持する証拠があります.
- このレビューは,機能的および腫瘍学的アウトカム,および焦点療法のためのフォローアップ戦略を詳細に述べています.
結論:
- 局所性前立腺がんの治療において 焦点療法が重要な要素として 確立されています
- 手術や放射線治療に代わる 有望な治療法であり 患者の生活の質を 維持する可能性があります
- 増加する証拠は,前立腺がんの治療の将来において,焦点療法の重要な可能性を強調しています.
さらに関連する動画
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

